Product
Influenza Hemagglutinin mRNA vaccine
1 clinical trial
2 indications
Indication
InfluenzaIndication
Influenza ImmunizationClinical trial
A Phase I, Parallel, Randomized, Active-controlled, Multi-center, Dose-escalation Study With Early Safety Data Reviews to Assess Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adults 18 Years of Age and OlderStatus: Completed, Estimated PCD: 2023-02-17